| License: Creative Commons Attribution 4.0 PDF - Published Version (998kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-448130
- DOI to cite this document:
- 10.5283/epub.44813
Hähnel, Viola ; Peterhoff, David 
; Bäuerlein, Veronika ; Brosig, Andreas-Michael ; Palmer, Irene ; Johnson, Christian ; Bica, Adelina ; Totir, Monica ; Ossner, Thomas ; Stemmer, Barbara ; Toelge, Martina ; Schütz, Anja ; Niller, Hans-Helmut ; Schmidt, Barbara ; Wagner, Ralf ; Gessner, Andre ; Burkhardt, Ralph ; Offner, Robert
; Bäuerlein, Veronika ; Brosig, Andreas-Michael ; Palmer, Irene ; Johnson, Christian ; Bica, Adelina ; Totir, Monica ; Ossner, Thomas ; Stemmer, Barbara ; Toelge, Martina ; Schütz, Anja ; Niller, Hans-Helmut ; Schmidt, Barbara ; Wagner, Ralf ; Gessner, Andre ; Burkhardt, Ralph ; Offner, Robert 
Abstract
The ongoing coronavirus disease 2019 (COVID-19) pandemic emerged in December 2019. Convalescent plasma represents a promising COVID-19 treatment. Here, we report on the manufacturing of a plasma-based product containing antibodies specific to SARS-CoV-2 obtained from recently recovered COVID-19 patients. Convalescent plasma donors were screened as follows: 1) previously confirmed SARS-CoV-2 ...
Owner only: item control page
Download Statistics